NASDAQ · OBIO
Orchestra BioMed Holdings, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for OBIO: Nov 9, 2026
Orchestra BioMed Holdings, Inc. Ordinary Shares is estimated to report earnings on 11/09/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 4 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.4. The reported EPS for the same quarter last year was $-0.4.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.40 | $-0.37 | $-0.45 | 4 |
| Dec 2026 | $-0.42 | $-0.38 | $-0.49 | 4 |
| Mar 2027 | $-0.37 | $-0.32 | $-0.42 | 2 |
| Jun 2027 | $-0.37 | $-0.32 | $-0.42 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Zacks · Fintel · BNK Invest- RTTNews · Oct 2, 3:26 AM EDTBiotech Stocks At 52-Week Highs – KOD, MASS, OBIO, CDNA, PMVP(RTTNews) – The following biotech stocks reached a 52-week high on October 1, 2026, driven by key catalysts such as promising results from clinical trials or revised financial guidance.
- Zacks · Sep 21, 7:33 AM EDTStrength Seen in Orchestra BioMed Holdings, Inc. (OBIO): Can Its 5.2% Jump Turn into More Strength?Orchestra BioMed Holdings, Inc. (OBIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
- RTTNews · Sep 15, 9:15 AM EDTOrchestra BioMed Receives $6.1 Million Milestone Payment From Vivasure Acquisition By Haemonetics(RTTNews) – Orchestra BioMed Holdings, Inc. (OBIO), a biomedical company focused on advancing high-impact technologies through strategic partnerships, announced the receipt of a $6.1 million milestone payment tied to Haemonetics Corporation's (HAE) acquisition of Vivasure Medical
- RTTNews · Sep 14, 9:37 AM EDTBiotech Stocks At 52-Week Highs – TXG, OBIO, AVAH, OSCR, LFST, TVTX(RTTNews) – The biotech stocks listed below reached a new 52-week high on September 11, 2026, owing to upcoming clinical readouts and positive financial results. 10x Genomics Inc. (TXG) 10x Genomics is a life science technology company that specializes in developing various a
- RTTNews · Sep 11, 5:37 AM EDTBiotech Stocks At 52-Week Highs – OBIO, AVAH, TVTX, TXG, LFST(RTTNews) – The following biotech stocks reached a 52-week high on September 10, 2026, driven by significant clinical developments or financial progress. Orchestra BioMed Holdings Inc. (OBIO) Orchestra BioMed is a biomedical company specializing in developing therapies for va
- Fintel · Sep 10, 3:51 PM EDTBTIG Upgrades Orchestra BioMed Holdings to Buy from NeutralFintel reports that on September 10, 2026, BTIG upgraded their outlook for Orchestra BioMed Holdings (NASDAQGM:OBIO) from Neutral to Buy. Prior to this rating action, the company's stock closed at $5.45 on September 9, 2026. The latest close was also recorded at $5.45 on Septembe
- RTTNews · Sep 10, 2:49 PM EDT5 Biotech Stocks In Spotlight: Tenon Medical, AEON Biopharma, Silexion, Orchestra BioMed & Indaptus(RTTNews) – Several biotech stocks were in focus Thursday, including Tenon Medical following the full repayment of its senior convertible promissory notes; AEON Biopharma after positive forced degradation study results for ABP-450; Silexion Therapeutics ahead of several September
- BNK Invest · Sep 8, 1:51 PM EDTTuesday 9/8 Insider Buying Report: ENOV, OBIOAs the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys. At Enovis, a filing with the SEC revealed that on Friday, Chief Executive Officer D
- RTTNews · Aug 19, 4:21 AM EDTBiotech Stocks At 52-Week Highs – AMLX +63% With Phase 3 Data, VOGX +25%, OBIO +19%, ATRC, CRL(RTTNews) – The following biotech stocks reached a 52-week high on August 18, 2026, primarily driven by positive quarterly reports.
- RTTNews · Aug 11, 5:48 AM EDTOrchestra Q2 Loss Widens On Higher Expenditure; Gains $35 Mln In Strategic Capital(RTTNews) – Orchestra BioMed Holdings, Inc. (OBIO) posted second-quarter financial results, with its net loss widening from the prior-year quarter, driven lower by higher interest expenses and the lack of partnership revenue.
- Zacks · Aug 10, 5:55 PM EDTOrchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Misses Revenue EstimatesOrchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of -8.57% and -32.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- RTTNews · Aug 10, 4:16 PM EDTOrchestra BioMed Holdings, Inc. Q2 Sales Decline(RTTNews) – Orchestra BioMed Holdings, Inc. (OBIO) announced Loss for second quarter of -$24.079 million
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Orchestra BioMed Holdings, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.